GSK, Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, a ...
DIOSynVax, a pioneering clinical-stage biotechnology company specializing in revolutionary broadly protective vaccines, showcased its latest data on a broadly reactive bird-flu vaccine. This research ...
Federal agencies are studying a case of human avian influenza in which the infected person did not have contact with affected ...
The U.S. government collaborates with GSK, Sanofi, and CSL to enhance bird flu vaccine production. This initiative aims to ...
CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the ...
U.S. health officials have run into obstacles in their efforts to determine whether a Missouri person infected with H5N1 bird ...
Find the latest Bird Flu news from WIRED. See related science and technology articles, photos, slideshows and videos.
GSK, Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, ...
The California Department of Public Health (CDPH) reported on Saturday that a third possible human case of bird flu has been ...